Base
HTS 3001Chapter 30

HTS 3001 — Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: Duty Rate & Import Guide

Pharmaceutical Products · 13 pending regulations · 15 court cases · $27.9M monthly imports · 100% from 1 countries · Updated daily from USITC

Duty Rates

General

Free

Special

Free

Column 2

Free

Trade Agreement Eligibility

CUSMAKORUS

Trade Intelligence

Monthly Imports

$27.9M

2026-01

Trade Concentration

100%

from top 3 of 1 origins

Regulatory Pressure

HIGH

0 rulings — · 13 reg · 8 CIT, 7 CAFC (2 recent)

Global Rates

🇺🇸 Free

🇬🇧 United Kingdom: N/A · 🇪🇺 European Union: N/A · 🇨🇦 Canada: N/A · 🇧🇷 Brazil: N/A

Compare All →

Data compiled from USITC HTS, US Census Bureau, Federal Register, CourtListener · As of 2026-04-29 · Updates monthly

Active DisputesRecent court cases or pending regulations affect this code
Regulatory Pressure

This code has elevated regulatory activity — 0 CBP rulings (0 in last 2 years, trend: stable), 13 pending Federal Register actions, and 15 CIT/CAFC cases.

Supply Chain Risk

100% of US imports for this code come from just 1 countries. High origin concentration increases exposure to trade disruptions or tariff escalations.

Subheadings (6)

CodeDescriptionRate
3001.20.00.00Extracts of glands or other organs or of their secretionsFree
3001.90.01OtherFree
3001.90.01.10Liver—
3001.90.01.50Other—
3001.90.01.65Heparin—
3001.90.01.95Other—

Federal Register (13)

Notice2019-10191
2019-05-17

Request for Comments Concerning Proposed Modification of Action Pursuant to Section 301: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

Request for comments and notice of public hearing.

Notice2018-15090
2018-07-17

Request for Comments Concerning Proposed Modification of Action Pursuant to Section 301: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

Request for comments and notice of public hearing.

Presidential Document2010-32610
2010-12-27

To Take Certain Actions Under the African Growth and Opportunity Act, and for Other Purposes

Notice2010-14236
2010-06-15

Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS

Institution of investigation and invitation to file written submissions.

Presidential DocumentE8-31137
2008-12-30

To Implement the Dominican Republic-Central America- United States Free Trade Agreement With Respect to Costa Rica and for Other Purposes

View all 13+ regulations on Federal Register →

Court of International Trade & Federal Circuit (15)

Nutricia North America, Inc. v. United States2025-11-17
24-1436Court of Appeals for the Federal Circuit
Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC2024-12-20
24-1936Court of Appeals for the Federal Circuit
Nagase & Co. v. United States2023-04-11
21-00574United States Court of International Trade
Janssen Ortho, LLC v. United States2021-04-26
20-1663Court of Appeals for the Federal Circuit
Janssen Ortho LLC v. United States2020-02-06
13-00296United States Court of International Trade
View all 15+ cases on PACER →

Matching Export Code (Schedule B)

3001200000Schedule B

EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS

Census Bureau export classification matching this HTS import code.

3001.20.00.00 →